ANDREW OSBECK: Open Payments
NPI 1730199506 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,128 in 103 payments from 17 companies in 2025. Trend: 2023 $1,866 · 2024 $1,917 · 2025 $2,128
Food & beverage: $1,996Education: $132
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $437 |
| ABBVIE INC. | 29 | $420 |
| Lilly USA, LLC | 8 | $314 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $302 |
| Celltrion USA Inc. | 5 | $99 |
| Madrigal Pharmaceuticals | 2 | $88 |
| Ipsen Biopharmaceuticals, Inc | 5 | $87 |
| Ardelyx, Inc. | 3 | $63 |
| PFIZER INC. | 3 | $63 |
| Novo Nordisk Inc | 2 | $56 |
Products named: TREMFYA, OMVOH, ENTYVIO, SKYRIZI, RINVOQ, VEGZELMA, REZDIFFRA, IQIRVO.
Industry payments across KS — which companies pay providers there.
